Early Academic Pursuits

He embarked on his academic journey with a strong foundation in biochemistry, earning his M.Sc. in Biochemistry from M.S. University, Baroda, India, in 1977. His academic pursuits continued as he pursued a Ph.D. in Biochemistry from the esteemed All India Institute of Medical Sciences, New Delhi, graduating in 1984. These early academic achievements laid the groundwork for his illustrious career in drug discovery and molecular biology.

Professional Endeavors

His professional journey has been marked by diverse experiences across various prestigious institutions. He began his career as a Senior Research Fellow at the Department of Biochemistry, All India Institute of Medical Sciences, New Delhi, India, from 1977 to 1984. Subsequently, he served as a Research Associate at the Molecular Biophysics Unit, Indian Institute of Science, Bangalore, India, from 1984 to 1986, followed by a stint as a Research Fellow at the Department of Molecular Genetics, Beckman Research Institute of the City of Hope, Duarte, California, from 1986 to 1988. He then transitioned to academia, serving as an Assistant Professor at the Department of Biophysics, University of Delhi, South Campus, New Delhi, from 1988 to 1992. Since 1992, he has been a Senior Scientist at the International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi, where he currently leads the Malaria Drug Discovery Group.

Contributions and Research Focus in Drug Discovery

His contributions to the field of drug discovery are significant and multifaceted. He has been actively involved in developing laboratory technologies for the production of gene products through both recombinant and chemical synthetic routes. Notably, his work includes the synthesis of human oxytocin and human adrenocorticotropic hormone, as well as the recombinant synthesis of human insulin. His research interests span various aspects of drug discovery, including molecular biology, medicinal chemistry, pharmacology, and bioinformatics. He has made significant strides in the design and synthesis of novel antibiotic peptides, with a focus on targeting bacterial symbionts associated with malaria parasites.

Accolades and Recognition

His contributions to drug discovery have earned him widespread recognition and accolades within the scientific community. His pioneering work in the design and synthesis of antibiotic peptides has been lauded for its potential in addressing antibiotic resistance and combating malaria. He has been awarded prestigious grants and fellowships, including the Drug Discovery Award, in recognition of his outstanding contributions to pharmaceutical research.

Impact and Influence

His research has had a profound impact on the field of drug discovery, particularly in the fight against malaria. His innovative approaches to designing novel antibiotic peptides and his efforts in identifying promising antimalarial compounds from natural sources have the potential to revolutionize malaria treatment strategies. His work serves as a testament to the transformative power of interdisciplinary research in addressing global health challenges.

Legacy and Future Contributions

Notable Publications

• Marmesin isolated from Celtis durandii Engl. root bioactive fraction inhibits β-hematin formation and contributes to antiplasmodial activity
• Innate functions of natural products: A promising path for the identification of novel therapeutics
• Identification of Novel, Potent, and Selective Compounds against Malaria Using Glideosomal-Associated Protein 50 as a Drug Target
• Antiplasmodial activity of the bulbs of Fritillaria cirrhosa D.Don (Syn: Fritillaria roylei Hook.): UPLC-IM-Q-TOF-MS/MS-based biochemometric approach for the identification of marker compounds
• Synthesis and anti-plasmodial activity of isoandrographolide acetals
• Chitosan-supported FeCl3 catalyzed multicomponent synthesis of tetrahydroisoquinoline-indole hybrids with promising activity against chloroquine resistant Plasmodium falciparum